LIU Lijing, MA Hongxin, DU Rui, DI Xiaoling, GU Hua. Effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome and its application in treatment[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 111-114. DOI: 10.7619/jcmp.20221820
Citation: LIU Lijing, MA Hongxin, DU Rui, DI Xiaoling, GU Hua. Effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome and its application in treatment[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 111-114. DOI: 10.7619/jcmp.20221820

Effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome and its application in treatment

More Information
  • Received Date: June 09, 2022
  • Available Online: November 17, 2022
  • Objective 

    To observe effect of a new lung ultrasound scoring method in evaluation of disease condition of neonatal respiratory distress syndrome (NRDS) and its application in treatment of pulmonary surfactant (PS).

    Methods 

    The clinical data of 91 children with NRDS were retrospectively analyzed, all children with NRDS were treated with PS. A total of 70 children who underwent physical examinations during the same period were selected as healthy control group. According to the clinical manifestations and X-ray examination results within 6 hours after birth, 91 children in the NRDS group were further divided into mild group (39 cases) and severe group (52 cases). The pulmonary ultrasound manifestations were compared between NRDS group and healthy control group, children with gestational age < 30 weeks and ≥ 30 weeks, and mild group and severe group. The LUS scores at different time points were compared between the mild and severe groups treated by PS.

    Results 

    The detection rates of lung consolidation, air bronchogram, B-line fusion, alveolar interstitial syndrome, pleural line abnormality and pleural effusion in the NRDS group were higher than those in healthy control group (P < 0.05). The detection rate of alveolar interstitial syndrome in children with gestational age < 30 weeks was lower than that in children with gestational age ≥ 30 weeks (P < 0.05). The detection rates of air bronchogram, B-line fusion, pleural line abnormality and pleural effusion in the severe group were higher than those in the mild group (P < 0.05). Before treatment, LUS score of the mild group was lower than that of the severe group (P < 0.05). At 12 and 24 h after treatment, the LUS scores of the two groups were decreased compared with those before treatment, and the LUS scores of the mild group were lower than those of the severe group (P < 0.05).

    Conclusion 

    LUS has an ideal value in the evaluation of NRDS, and can be used as an effective evaluation method for PS treatment of NRD.

  • [1]
    臧月珍, 杨阳阳, 吕媛, 等. 不同胎龄新生儿呼吸窘迫综合征早产儿血细胞分析指标及临床特点[J]. 实用临床医药杂志, 2021, 25(1): 69-73. doi: 10.7619/jcmp.20200938
    [2]
    赵媛, 刘克战, 张新华. 微创肺表面活性物质给药治疗新生儿呼吸窘迫综合征的临床研究[J]. 中国基层医药, 2020, 27(8): 940-944. doi: 10.3760/cma.j.issn.1008-6706.2020.08.011
    [3]
    赵苑竹, 刘丹, 林明名. 肺部超声评分与简化临床肺部感染评分对VAP早期诊断与预后评估的价值[J]. 河北医科大学学报, 2021, 42(6): 698-703. doi: 10.3969/j.issn.1007-3205.2021.06.017
    [4]
    陈少军, 陈全景, 周凤霞. 肺表面活性物质联合无创正压通气对新生儿呼吸窘迫的疗效观察及对血气指标的影响[J]. 河北医学, 2020, 26(3): 411-415. doi: 10.3969/j.issn.1006-6233.2020.03.014
    [5]
    杨子慧, 李亚超, 于蓓. 肺部超声与胸部X线在新生儿呼吸窘迫综合征中的诊断价值[J]. 临床和实验医学杂志, 2021, 20(24): 2686-2688, 后插1. doi: 10.3969/j.issn.1671-4695.2021.24.031
    [6]
    REAMAROON N, SJODING MW, DERKSEN H, et al. Robust segmentation of lung in chest x-ray: applications in analysis of acute respiratory distress syndrome [J]. BMC Med Imaging, 2020, 20(1): 116.
    [7]
    王卫卫, 张红伟, 崔清洋, 等. 肺部12分区超声评分法在新生儿呼吸窘迫综合征中的应用价值[J]. 新乡医学院学报, 2022, 39(3): 252-257. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYX202203011.htm
    [8]
    石永言, 富建华. 《2019年欧洲呼吸窘迫综合征管理指南》解读[J]. 中国实用儿科杂志, 2019, 34(6): 461-465, 516. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201906004.htm
    [9]
    顾彩虹, 谢永鹏, 郑涛, 等. 肺部超声评分对腹腔感染机械通气患者脱机结局的预测价值[J]. 中华危重病急救医学, 2020, 32(1): 94-98.
    [10]
    中华医学会儿科学分会围产医学专业委员会, 中国医师协会新生儿科医师分会超声专业委员会, 中国医药教育协会超声医学专业委员会重症超声学组, 等. 新生儿肺脏疾病超声诊断指南[J]. 中国当代儿科杂志, 2019, 21(2): 105-113. https://www.cnki.com.cn/Article/CJFDTOTAL-DDKZ201902001.htm
    [11]
    沈鸥羽. 不同通气方式对肺泡表面活性物质治疗的呼吸窘迫综合征早产儿脑氧代谢水平的影响[J]. 中国妇幼保健, 2021, 36(20): 4742-4745. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202120033.htm
    [12]
    韩晗, 李晓霞, 帅向华, 等. 不同时间肺泡表面活性物质治疗NRDS临床疗效观察[J]. 浙江医学, 2020, 42(12): 1278-1281. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202012014.htm
    [13]
    于雅美, 蒋鹏, 姜玉芝, 等. 超声与胸部X线检查对新生儿呼吸窘迫综合征的诊断效能研究[J]. 中国医刊, 2021, 56(6): 633-635. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI202106018.htm
    [14]
    左莉莉, 陈辉, 秦振英, 等. 肺部超声在新生儿呼吸窘迫综合征临床诊断及肺泡表面活性物质治疗效果评估中的应用价值[J]. 现代生物医学进展, 2020, 20(19): 3678-3682. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202019015.htm
    [15]
    樊静, 谢晓曼, 张传龙. NRDS患儿联合应用NIPPV与PS的临床应用价值及预后效果追踪[J]. 湖南师范大学学报: 医学版, 2021, 18(6): 128-131. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYG202106037.htm
  • Cited by

    Periodical cited type(2)

    1. 陈维平,谢芸. Hp感染对高血压患者血管内皮损伤及微炎症反应的影响观察. 中国医学创新. 2022(15): 136-139 .
    2. 杨苹,黄冠华. 高血压人群中幽门螺杆菌感染与颈动脉粥样硬化的关系. 内蒙古医学杂志. 2022(05): 530-536 .

    Other cited types(2)

Catalog

    Article views (184) PDF downloads (6) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return